Welcome to the Sickle Cell Center at The Children's Hospital of Philadelphia. Our Center has two components — clinical care and research.
Our Sickle Cell Clinical Program is one of the largest in the United States. We provide comprehensive care and services to more than 700 patients at the Main Hospital and approximately 200 patients at Pediatric & Adolescent Specialty Care, Voorhees, Pediatric & Adolescent Specialty Care Center in King of Prussia, PA and other off-campus locations.
Much of our research is conducted under our Comprehensive Sickle Cell Center. We are one of 10 such centers in the nation funded on a competitive basis by the National Heart, Lung and Blood Institute of the National Institutes of Health.
The Division of Hematology, to which the Sickle Cell Center belongs, has pioneered research in diagnosis, treatment and prevention of stroke in children with sickle cell disease.
Learn more about our Center research projects.
Kwaku Ohene-Frempong, MD, Professor of Pediatrics at the University of Pennsylvania School of Medicine, directs both the clinical and research components of the Center. Dr. Ohene-Frempong is an internationally recognized authority on sickle cell disease whose wide-ranging interests include the management of sickle cell complications, particularly cerebrovascular disease in children. Kim Smith-Whitley, MD, is medical director of the clinical program and clinical director of the Division of Hematology.
To make an appointment at the Main Hospital or to learn more about our studies, call 215-590-3437. To make an appointment in our Pediatric & Adolescent Specialty Care, Voorhees office, call 856-435-7502. To make an appointment in our Pediatric & Adolescent Specialty Care Center in King of Prussia, PA office, call 267-426-7492.